Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Pediatrix Medical
MD
$2.2B
| $1.45M | ﹤0.01% |
155,505
+89,967
| +137% | +$931K |
|
3102
Compass Minerals
CMP
$1.15B
| $1.45M | ﹤0.01% |
57,103
+36,812
| +181% | +$940K |
|
3103
German American Bancorp
GABC
$1.9B
| $1.45M | ﹤0.01% |
44,595
+34,072
| +324% | +$994K |
|
3104
Bright Horizons
BFAM
$3.86B
| $1.44M | ﹤0.01% |
15,304
-54,220
| -78% | -$4.62M |
|
3105
QuinStreet
QNST
$1.21B
| $1.44M | ﹤0.01% |
112,423
+59,878
| +114% | +$674K |
|
3106
PubMatic
PUBM
$810M
| $1.44M | ﹤0.01% |
88,188
+55,322
| +168% | +$802K |
|
3107
Healthcare Services Group
HCSG
$1.53B
| $1.44M | ﹤0.01% |
138,387
+95,248
| +221% | +$951K |
|
3108
Covenant Logistics
CVLG
$872M
| $1.43M | ﹤0.01% |
62,322
+7,200
| +13% | +$154K |
|
3109
CALL
Ultragenyx Pharmaceutical
RARE
$2.55B
| $1.43M | ﹤0.01% |
+30,000
| New | +$1.16M |
|
|
3110
PUT
Ultragenyx Pharmaceutical
RARE
$2.55B
| $1.43M | ﹤0.01% |
+30,000
| New | +$1.16M |
|
3111
Fulgent Genetics
FLGT
$527M
| $1.43M | ﹤0.01% |
49,534
+35,904
| +263% | +$961K |
|
3112
Usana Health Sciences
USNA
$286M
| $1.43M | ﹤0.01% |
26,702
+12,143
| +83% | +$614K |
|
3113
Sana Biotechnology
SANA
$980M
| $1.43M | ﹤0.01% |
350,614
+145,047
| +71% | +$534K |
|
3114
HealthStream
HSTM
$840M
| $1.43M | ﹤0.01% |
52,840
+23,032
| +77% | +$572K |
|
3115
Core Laboratories
CLB
$521M
| $1.43M | ﹤0.01% |
80,866
+53,229
| +193% | +$1.07M |
|
3116
ARKO Corp
ARKO
$635M
| $1.43M | ﹤0.01% |
172,751
+95,970
| +125% | +$735K |
|
|
SWI
3117
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.42M | ﹤0.01% |
113,985
+93,165
| +447% | +$1M |
|
3118
TTEC Holdings
TTEC
$124M
| $1.42M | ﹤0.01% |
65,616
+46,287
| +239% | +$974K |
|
3119
Transcat
TRNS
$871M
| $1.42M | ﹤0.01% |
13,005
+10,300
| +381% | +$991K |
|
3120
ATN International
ATNI
$492M
| $1.42M | ﹤0.01% |
36,463
+11,870
| +48% | +$392K |
|
3121
CALL
Rocket Pharmaceuticals
RCKT
$394M
| $1.42M | ﹤0.01% |
+47,400
| New | +$1.05M |
|
|
3122
PUT
Rocket Pharmaceuticals
RCKT
$394M
| $1.42M | ﹤0.01% |
+47,400
| New | +$1.05M |
|
3123
Team
TISI
$77.7M
| $1.42M | ﹤0.01% |
215,000
| – | – |
|
|
OPTU
3124
Optimum Communications Inc
OPTU
$301M
| $1.42M | ﹤0.01% |
436,188
+355,763
| +442% | +$932K |
|
3125
SentinelOne
S
$7.34B
| $1.41M | ﹤0.01% |
51,551
-13,962
| -21% | -$270K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.